Navigation Links
UH chemist developing materials to detect, repel E. coli
Date:6/15/2011

HOUSTON, June 15, 2011 A University of Houston (UH) chemist who is developing materials for detecting and repelling E. coli has published papers in two high-impact journals this month.

Rigoberto "Gobet" Advincula, a polymer chemist, says he and his colleagues have developed two different materials that are both equally effective against E. coli. He discusses the findings in the June issues of Chemical Communications (ChemComm) and Chemistry of Materials.

The ChemComm paper, Advincula says, describes a graphene material that is proving to be an effective antimicrobial, while the research appearing in the journal Chemistry of Materials uses a conducting polymer that can repel E. coli. He says his team has created a smart film that not only can be used to turn bacterial adhesion on and off, but also may be used for detecting bacteria. The work was done in collaboration with Debora Rodrigues and her group from UH's department of civil and environmental engineering.

Prolific in inventing new and smart materials such as these, Advincula has compiled an impressive record as a leading polymer, thin films and nanomaterials researcher. In addition to these most recent publications, three other papers were cover stories in top journals in April. In May, he released a new book with Wolfgang Knoll of the Austrian Institute of Technology titled "Functional Polymer Films" that Advincula considers to be akin to an encyclopedia on polymer thin films.

Additionally, Advincula was recently inducted as a fellow of the American Chemical Society (ACS), as well as being named a fellow in two of its technical divisions the Polymer Chemistry Division and the Polymer Materials Science and Engineering Division. The ACS is the world's largest scientific society and one of the world's leading sources of authoritative scientific information. Achieving fellow status is a competitive process, based on research, contribution and service accomplishments to science and society.

"It is a rare distinction to become a triple fellow with the ACS, which has more than 163,000 members," Advincula said. "With only one out of every 1,000 members qualifying for selection as a fellow, I am extremely honored to achieve this trifecta for my work in advancing polymer and nanomaterial research and applications."

He asserts that much of this is really a tribute to his research group at UH, saying that his discovery-driven laboratory provides an environment that allows for readily filing patents, authoring publications and mentoring future scholars and inventors. He says the joy of working with students and budding scientists and engineers is reflected in his record of mentoring, with nearly 20 Ph.D. students, 50 undergraduates and dozens of high school students coming through his lab over the years.

"It is an extraordinary achievement to be named a fellow of the ACS and two ACS divisions," said David Hoffman, professor and chair of the chemistry department in the College of Natural Sciences and Mathematics at UH. "The honors are a reflection of the respect Gobet's colleagues have for him personally and for his scientific work."

In addition to his lab research, Advincula has been active in ACS, giving hundreds of presentations, organizing symposia and serving on the editorial advisory board of several scientific journals. He has nine U.S. patents and has authored more than 300 papers. Advincula, who is both a professor of chemistry and chemical engineering, has been continuously funded by the National Science Foundation, Robert A. Welch Foundation and several companies interested in the applications of his work.


'/>"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
Source:Eurekalert  

Related medicine news :

1. Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of their Chemistry Services Agreement
2. Tastier MRE: Chemistry gives battlefield chow a gourmet flare
3. Subtyping breast cancer by immunohistochemistry to investigate survival terms
4. Basque researchers apply chemistry to restoration of paintings and dating of signatures
5. Pfizer joins open-access medicinal chemistry public-private collaboration
6. MIT moves toward greener chemistry
7. Biochemist studies DNA repair with $787,000 in grants
8. 2010 Chemistry Nobel laureate Ei-ichi Negishi leads C&EN webinar
9. MIT chemists engineer plants to produce new drugs
10. Medicinal chemist wins inaugural De Burgh Fellowship
11. UH biochemist works to revolutionize ovarian cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UH chemist developing materials to detect, repel E. coli
(Date:4/25/2017)... ... April 25, 2017 , ... As Spring reignites ... defects research related to Zika virus during pregnancy, as well as other prenatal ... important science. , The Teratology Society is an international and ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the ... or chronic problems, I focus on preventative care with all my patients to alleviate possible ... questions, always feel free to contact my office and my trained staff will assist you ...
(Date:4/25/2017)... ... 25, 2017 , ... There is no better place in South Florida to ... in the May issue of Consumer Reports focused on heart health. , The ... during and after coronary bypass and aortic valve replacement procedures. , Consumer Reports ...
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College is introducing ... advance their careers. Beginning in the fall of 2017, Emmanuel’s program will allow registered ... few as 16 months and for as little as $14,528. These changes will enable ...
(Date:4/24/2017)... ... ... The Santana Telehealth Project was honored with the 2017 ATA Humanitarian Award. The ... conference, on April 23 in Orlando, FL. , “I am proud that ATA is ... poor and underserved in other parts of the world,” said Jonathan Linkous, CEO of ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
(Date:4/19/2017)... , April 19, 2017 Global Prostate ... report on the prostate cancer therapeutics market analyzes ... market. Increasing prevalence of prostate cancer, launch of ... the development of new drugs & therapeutic biological ... drug due to lesser side effects are some ...
Breaking Medicine Technology: